Evaluation of depth and thickness in skin, subcutaneous and muscle tissue at vaccination sites in Japanese infants

Evaluation of depth and thickness in skin, subcutaneous and muscle tissue at vaccination sites in Japanese infants - Evaluation of depth and thickness in skin, subcutaneous and muscle tissue at vaccination sites in Japanese infants

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017591

Enrollment

180

Registered

2015-05-16

Start date

2015-08-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Using an ultrasonic echo, obtains the tomographic image information about the structure of skin and muscle tissue .

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Infant whose written consent form is obtained from his/her representative for participation in this study. (2) Infant obtained written consent form from his.her representative at the age of 2, 3, 4, 5, 6, or 12-15 months old. (3) Infant who has grown stably after birth. Even if an infant was suffering not severe transient acute disease or not severe chronic disease(common cold, upper respiratory inflammation, etc), participation in this study would be allowed when investigator medically judges the disease dose not affect the measurement items. (4) Japanese(the infant was born in Japan, and his/her all 4 grandparents are Japnese with speaking Japanease)

Exclusion criteria

Exclusion criteria: (1) infant who has an abnormality in the measurement target site. (2) infant with who investigator judges stable and circumference measurements and image inspection is difficult. (3) infant who is suffering from severe acute and chronic disease. (4) infant who has an experience of any damage in the arms or legs. (5) infant who has or experienced all of neurological or muscle disease. (6) Other, infant who investigator judges ineligible as a subject. (7) infant whose written consent form is not obtained by his/her representative's own free will.

Countries

Japan

Contacts

Public ContactKeitaro Yatabe

Japan Vaccine Co.,Ltd Clinical Development & Medical Affairs Division, Medical Affairs Group

yatabe.keitaro.d7@japanvaccine.co.jp03-5213-2735

Outcome results